Preclinical Studies of Chemotherapy Using Histone Deacetylase Inhibitors in Endometrial Cancer

Because epigenetic alterations are believed to be involved in the repression of tumor suppressor genes and promotion of tumorigenesis in endometrial cancers, novel compounds endowed with a histone deacetylase (HDAC) inhibitory activity are an attractive therapeutic approach. In this review, we discu...

Descripción completa

Detalles Bibliográficos
Autores principales: Takai, Noriyuki, Narahara, Hisashi
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821626/
https://www.ncbi.nlm.nih.gov/pubmed/20169171
http://dx.doi.org/10.1155/2010/923824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821626/
https://www.ncbi.nlm.nih.gov/pubmed/20169171
http://dx.doi.org/10.1155/2010/923824

Ejemplares similares